206 related articles for article (PubMed ID: 14691048)
21. Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells.
Muscella A; Elia MG; Greco S; Storelli C; Marsigliante S
J Cell Physiol; 2003 May; 195(2):234-40. PubMed ID: 12652650
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.
Hudry-Clergeon H; Stengel D; Ninio E; Vilgrain I
FASEB J; 2005 Apr; 19(6):512-20. PubMed ID: 15791001
[TBL] [Abstract][Full Text] [Related]
23. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function.
Kojima H; Shinagawa A; Shimizu S; Kanada H; Hibi M; Hirano T; Nagasawa T
Exp Hematol; 2001 May; 29(5):616-22. PubMed ID: 11376875
[TBL] [Abstract][Full Text] [Related]
24. cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway.
Shen B; Kwan HY; Ma X; Wong CO; Du J; Huang Y; Yao X
J Biol Chem; 2011 Jun; 286(22):19439-45. PubMed ID: 21487005
[TBL] [Abstract][Full Text] [Related]
25. 14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils.
Burgos RA; Hidalgo MA; Monsalve J; LaBranche TP; Eyre P; Hancke JL
Planta Med; 2005 Jul; 71(7):604-8. PubMed ID: 16041644
[TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.
Liang L; Jiang J; Frank SJ
Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B.
Munir I; Fukunaga K; Miyazaki K; Okamura H; Miyamoto E
J Reprod Fertil; 1999 Sep; 117(1):49-59. PubMed ID: 10645245
[TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils.
McLaughlin NJ; Banerjee A; Khan SY; Lieber JL; Kelher MR; Gamboni-Robertson F; Sheppard FR; Moore EE; Mierau GW; Elzi DJ; Silliman CC
J Immunol; 2008 Jun; 180(12):8192-203. PubMed ID: 18523285
[TBL] [Abstract][Full Text] [Related]
29. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
30. Pertussis toxin activates tyrosine kinase signaling cascade in myelomonocytic cells: a mechanism for cell adhesion.
Li H; Wong WS
Biochem Biophys Res Commun; 2001 May; 283(5):1077-82. PubMed ID: 11355882
[TBL] [Abstract][Full Text] [Related]
31. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
32. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
Chiou WF; Tsai HR; Yang LM; Tsai WJ
Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
[TBL] [Abstract][Full Text] [Related]
33. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
34. Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways.
MartÃnez D; Vermeulen M; Trevani A; Ceballos A; Sabatté J; Gamberale R; Alvarez ME; Salamone G; Tanos T; Coso OA; Geffner J
J Immunol; 2006 Jan; 176(2):1163-71. PubMed ID: 16394005
[TBL] [Abstract][Full Text] [Related]
35. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils.
Ferby IM; Waga I; Sakanaka C; Kume K; Shimizu T
J Biol Chem; 1994 Dec; 269(48):30485-8. PubMed ID: 7982965
[TBL] [Abstract][Full Text] [Related]
36. Lyn- and ERK-mediated vs. Ca2+ -mediated neutrophil O responses with thermal injury.
Fazal N; Al-Ghoul WM; Schmidt MJ; Choudhry MA; Sayeed MM
Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1469-79. PubMed ID: 12372808
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.
Germack R; Dickenson JM
Br J Pharmacol; 2004 Jan; 141(2):329-39. PubMed ID: 14751870
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological analysis of protein kinases responsible for chemotaxis of rat peritoneal neutrophils.
Xiao YQ; Minami K; Mue S; Ohuchi K
Eur J Pharmacol; 1998 Nov; 360(2-3):195-204. PubMed ID: 9851586
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction.
Bando H; Ikuno Y; Hori Y; Sayanagi K; Tano Y
Exp Eye Res; 2006 Mar; 82(3):529-37. PubMed ID: 16289050
[TBL] [Abstract][Full Text] [Related]
40. The upstream regulation of p38 mitogen-activated protein kinase phosphorylation by arachidonic acid in rat neutrophils.
Chang LC; Wang JP
J Pharm Pharmacol; 2000 May; 52(5):539-46. PubMed ID: 10864142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
